MISHA KUCHEROV: Open Payments
NPI 1821158163 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,909 in 232 payments from 44 companies in 2025. Trend: 2023 $5,771 · 2024 $5,540 · 2025 $5,909
Food & beverage: $5,737Education: $172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $794 |
| Amneal Pharmaceuticals LLC | 14 | $306 |
| SK Life Science, Inc. | 10 | $299 |
| Janssen Biotech, Inc. | 5 | $268 |
| Eisai Inc. | 6 | $252 |
| Lundbeck LLC | 6 | $251 |
| HARMONY BIOSCIENCES LLC | 7 | $239 |
| JAZZ PHARMACEUTICALS INC. | 13 | $218 |
| PFIZER INC. | 10 | $200 |
| Axsome Therapeutics, Inc. | 11 | $196 |
Products named: UBRELVY, CREXONT, Leqembi, QULIPTA, EPIDIOLEX, VRAYLAR, VYEPTI, FYCOMPA.
Industry payments across NY — which companies pay providers there.
